Why Is Dilantin So Hard to Find? [Explained for 2026]

If you've been trying to fill your Dilantin prescription and keep hitting roadblocks, you're not alone. Phenytoin — the active ingredient in Dilantin — has a long and complicated supply history. In 2026, extended-release capsules are generally available, but intermittent spot shortages with specific manufacturers continue to frustrate patients across the country. This guide breaks down exactly why Dilantin is so hard to find and what you can do today.

What Is Dilantin and Who Takes It?

Dilantin is the brand name for phenytoin sodium, an anticonvulsant medication that has been FDA-approved since 1939. It is used to control tonic-clonic (grand mal) seizures and complex partial seizures, and to prevent seizures during or after neurosurgery. Millions of Americans with epilepsy depend on it, making any supply disruption a serious safety concern.

Phenytoin is manufactured by Viatris under the Dilantin brand and by several generic manufacturers. It comes in extended-release capsules (30 mg, 100 mg), chewable tablets (50 mg), and oral suspension (125 mg/5 mL). Each formulation has had its own supply challenges at different times.

Why Does Dilantin Keep Running Out? The Key Reasons

Several factors have combined to make Dilantin supply unpredictable over the years:

Narrow therapeutic index (NTI) status. The FDA classifies phenytoin as a narrow therapeutic index drug, meaning the difference between a therapeutic dose and a toxic dose is small. This makes supply continuity critical — patients cannot easily switch manufacturers or formulations without careful blood level monitoring.

Product discontinuations. In 2023–2024, Viatris discontinued its 240 mL oral suspension bottles, shifting demand toward extended-release capsules and the remaining Dilantin-125 suspension in smaller bottles. This created a ripple effect across supply chains.

Manufacturing issues. Phenytoin has a history of manufacturer-specific shortages. In 2011, Pfizer faced a Dilantin 30 mg shortage due to a manufacturing issue. In 2022, the injectable form entered a shortage that wasn't fully resolved until 2025 when Hikma's 5 mL vials became consistently available.

Active ingredient sourcing. Like many generic drugs, generic phenytoin relies on active pharmaceutical ingredient (API) suppliers, often overseas. Disruptions in the API supply chain can trigger shortages across multiple manufacturers simultaneously.

Multiple manufacturer dependency. When one or two generic manufacturers experience shortages, the remaining ones cannot always absorb the increased demand quickly — leading to regional and pharmacy-specific outages.

What Is the Dilantin Shortage Status in 2026?

As of 2026, extended-release phenytoin capsules are generally available from multiple manufacturers, but patients continue to experience intermittent spot shortages with specific brands. The Dilantin-125 oral suspension (125 mg/5 mL) has faced ongoing back-order issues, with Viatris estimating resolution in mid-2025 — though supply remains tight heading into 2026. The injectable phenytoin shortage, which began in December 2022, was resolved by August 2025 when Hikma's 5 mL vials became consistently available.

The practical effect: your local pharmacy may have phenytoin from one manufacturer out of stock while another manufacturer's version is available nearby. But because phenytoin is a narrow therapeutic index drug, your doctor may not want you switching between manufacturers without monitoring — making this more complicated than most supply substitutions.

Why Can't You Just Switch to Any Available Phenytoin?

This is one of the most frustrating aspects of a Dilantin shortage. With most medications, switching from one generic manufacturer to another is straightforward. With phenytoin, it's more complicated:

Phenytoin has a narrow therapeutic window of 10–20 mcg/mL. Small changes in bioavailability between products can push levels too high (causing toxicity) or too low (causing breakthrough seizures).

State pharmacy laws vary on whether pharmacists can substitute a different manufacturer's product without prescriber approval. Some states require prescriber sign-off before the switch.

Switching between the free acid form (used in Infatabs and Dilantin-125 suspension) and the sodium salt form (used in capsules) requires an approximately 8% dose adjustment because the two forms have different drug content by weight.

If you must switch manufacturers or formulations due to a shortage, your doctor may want to check a trough blood level 1–2 weeks after the change and again at 4 weeks to confirm therapeutic levels.

What Should You Do If You Can't Find Dilantin?

Here are practical steps to take when your pharmacy doesn't have your Dilantin in stock:

Call multiple pharmacies. Don't assume all pharmacies are out. Availability varies from store to store, even within the same chain. Check independent pharmacies as well — they sometimes stock what chain pharmacies don't.

Use medfinder. medfinder calls pharmacies near you to find out which ones actually have your medication in stock, so you don't have to spend hours on hold.

Contact your doctor immediately. Do NOT stop taking Dilantin on your own. Abrupt discontinuation can precipitate status epilepticus, a life-threatening emergency. Your doctor needs to know about supply issues so they can help.

Ask about a different formulation. If your standard capsule brand is unavailable, your doctor may be able to work with you on temporarily using a different available formulation with careful monitoring.

Ask about alternatives. If shortages are persistent, your neurologist may discuss switching to another seizure medication like levetiracetam (Keppra) or lamotrigine (Lamictal). See our guide on

Read more: Alternatives to Dilantin if You Can't Fill Your Prescription

How to Find Dilantin in Stock Near You in 2026

The most effective approach is to cast a wide net across pharmacies. Check chain pharmacies, independent pharmacies, and mail-order options. Our detailed guide on finding Dilantin in stock near you walks through the best tools, including medfinder — which does the calling for you so you can stay focused on your health.

Remember: never ration, skip, or abruptly stop phenytoin doses without medical supervision. Seizure control is critical, and your healthcare team is your most important ally when supply issues arise.